Abteilung für Molekulare Genetik, Institut für Mikrobiologie und Genetik, Göttinger Zentrum für Molekulare Biowissenschaften (GZMB), Georg-August Universität Göttingen, Germany.
Department of Physical Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Nucleic Acids Res. 2019 May 21;47(9):4798-4813. doi: 10.1093/nar/gkz177.
Translation termination requires eRF1 and eRF3 for polypeptide- and tRNA-release on stop codons. Additionally, Dbp5/DDX19 and Rli1/ABCE1 are required; however, their function in this process is currently unknown. Using a combination of in vivo and in vitro experiments, we show that they regulate a stepwise assembly of the termination complex. Rli1 and eRF3-GDP associate with the ribosome first. Subsequently, Dbp5-ATP delivers eRF1 to the stop codon and in this way prevents a premature access of eRF3. Dbp5 dissociates upon placing eRF1 through ATP-hydrolysis. This in turn enables eRF1 to contact eRF3, as the binding of Dbp5 and eRF3 to eRF1 is mutually exclusive. Defects in the Dbp5-guided eRF1 delivery lead to premature contact and premature dissociation of eRF1 and eRF3 from the ribosome and to subsequent stop codon readthrough. Thus, the stepwise Dbp5-controlled termination complex assembly is essential for regular translation termination events. Our data furthermore suggest a possible role of Dbp5/DDX19 in alternative translation termination events, such as during stress response or in developmental processes, which classifies the helicase as a potential drug target for nonsense suppression therapy to treat cancer and neurodegenerative diseases.
翻译终止需要 eRF1 和 eRF3 将多肽和 tRNA 从终止密码子上释放出来。此外,还需要 Dbp5/DDX19 和 Rli1/ABCE1;然而,它们在这个过程中的功能目前尚不清楚。我们通过体内和体外实验的组合表明,它们调节终止复合物的逐步组装。Rli1 和 eRF3-GDP 首先与核糖体结合。随后,Dbp5-ATP 将 eRF1 递送到终止密码子,从而防止 eRF3 过早进入。Dbp5 在通过 ATP 水解放置 eRF1 后解离。这反过来又使 eRF1 能够与 eRF3 接触,因为 Dbp5 和 eRF3 与 eRF1 的结合是相互排斥的。Dbp5 指导的 eRF1 递位缺陷导致 eRF1 和 eRF3 与核糖体过早接触和过早解离,并导致随后的终止密码子通读。因此,Dbp5 控制的终止复合物逐步组装对于正常的翻译终止事件是必不可少的。我们的数据还表明,Dbp5/DDX19 可能在替代翻译终止事件中发挥作用,例如在应激反应或发育过程中,这将该解旋酶归类为无意义抑制治疗癌症和神经退行性疾病的潜在药物靶点。